Clinical profile and long-term predictors of mortality in idiopathic acute pulmonary thromboembolism

TL;DR

This study identifies risk factors and long-term mortality predictors in patients with unprovoked pulmonary embolism, highlighting the role of cardiovascular conditions.

Contribution

The study provides new insights into long-term mortality predictors for idiopathic pulmonary embolism patients.

Findings

In-hospital mortality was 15.9%, rising to 25.76% at three years.

Diabetes, hypertension, and lower TAPSE/PASP were linked to higher mortality.

Thrombolysis was associated with lower odds of mortality.

Abstract

Background: Unprovoked venous thromboembolism is a poorly understood entity. Clinical risk factors and future outcomes are not well recognized in this subgroup of patients. Various pathogenic mechanisms like inflammation and athero-thrombosis have been put forth but remain investigative. Our study aimed to determine the clinical profile and predictors of mortality in patients with idiopathic pulmonary embolism.

Methods: Our single centre observational study included 510 consecutive patients with symptomatic unprovoked venous thromboembolism. Pulmonary embolism (PE) patients were initially categorized based on the presence or absence of deep vein thrombosis (DVT). Subsequently, the patients were further sub-grouped according to mortality, and the association between clinical parameters and death was evaluated through regression analysis.

Results: The in-hospital mortality of patients with unprovoked pulmonary embolism was 15.9% and 25.76% at three year follow up. Significantly higher number of patients with diabetes, hypertension, dyslipidaemia, lower TAPSE (tricuspid annular plane systolic excursion) and PASP (pulmonary arterial systolic pressure) were found in mortality patients compared to survivor patients. On regression analysis we found significant association of higher odds of age OR = 1.1 (1.05–1.23), diabetes OR = 2.47 (1.28–4.79), hypertension OR = 2.25 (1.19–4.26) and lower odds of thrombolysis OR = 0.38 (0.11–0.59) with mortality. On Kaplan Meier survival analysis, the log value of <0.05 showed significantly higher mortality in patients who were not thrombolyzed.

Conclusion: Various short and long-term predictors of mortality exist for pulmonary embolism. Cardiovascular risk factors play a mediating role in venous thromboembolism and also serve as predictors for long-term mortality. Therefore, modifying these risk factors can potentially result in a reduction in long-term mortality.

Figures